37466-88-9

Usage

Uses

Used in Pharmaceutical Industry:
Ethyl 2,3-diaMinobenzoate is used as a local anesthetic for its capacity to prevent the generation and conduction of electrical signals in nerve fibers, making it an effective pain-relieving agent in topical creams and ointments.
Used in Cardiology:
In the field of cardiology, ethyl 2,3-diaMinobenzoate is utilized as an antiarrhythmic agent, helping to regulate abnormal heart rhythms by influencing the electrical activity of the heart.
Used in Synthesis of Pharmaceuticals:
Ethyl 2,3-diaMinobenzoate is employed as a key intermediate in the synthesis of other pharmaceutical compounds, contributing to the development of new medications.
Used in Biological Research:
As a fluorescent probe, ethyl 2,3-diaMinobenzoate is used in biological studies to aid in the visualization and tracking of cellular processes and molecular interactions.
Safety Note:
It is crucial to handle ethyl 2,3-diaMinobenzoate with caution due to its potential harmful effects if ingested or inhaled, and its capacity to cause skin and eye irritation. Proper safety measures should be implemented during its use in both medical and research applications.

Upstream product

• 61063-11-4 2-Amino-3-nitrobenzoic acid,ethyl ester 
• 64-17-5 ethanol 
• 54002-28-7 3-acetylamino-2-nitro-benzoic acid 

Downstream Products

• 109744-86-7 2-(4-methylphenyl)-4-benzimidazolecarboxylic acid ethyl ester 
• 560086-13-7 ethyl 2-(2-nitrophenyl)-1H-benzimidazole-4-carboxylate 
• 1314951-83-1 C₇H₁₀N₄O 
• 832099-52-2 Ethyl 2-amino-3-isopropylamino-benzoate 
• 266993-61-7 2-(3-(2-(N,N-diethylamino)eth-1-yloxy)phenyl)-benzimidazol-4-carboxylic acid ethyl ester 
• 266993-59-3 2-(4-(2-(N,N-diethylamino)eth-1-yloxy)phenyl)-benzimidazol-4-carboxylic acid ethyl ester 
• 266993-65-1 2-(4-(1-imidazolyl)phenyl)-benzimidazol-4-carboxylic acid ethyl ester 
• 928387-84-2 C₁₇H₂₂N₂O₃ 
• 1350454-17-9 ethyl 2-amino-3-[(4-methoxybenzoyl)amino]benzoate 
• 365462-49-3 3-[(4-methoxybenzoyl)amino]-2-{[4-(4-methyl-1,4-diazepan-1-yl)benzoyl]amino}benzoic acid hydrochloride 
• 365462-45-9 ethyl 3-[(4-methoxybenzoyl)amino]-2-{[4-(4-methyl-1,4-diazepan-1-yl)benzoyl]amino}benzoate hydrochloride 
• 765891-23-4 C₃₀H₃₄N₄O₅ 
• 201412-02-4 4-ethyl formate-2-phenylbenzimidazole 
• 201412-27-3 ethyl 2-(2-phenylethyl)benzimidazole-4-carboxylate p-toluenesulfonate 

Relevant academic research and scientific papers

INTERMEDIATE COMPOUNDS FOR THE PREPARATION OF ANGIOTENSIN II ANTAGONISTS

The present invention relates to novel substituted biphenyltetrazole compounds useful as intermediates in the preparation of angiotensin II antagonists, to a process for the synthesis of them and to a process for the conversion thereof to said molecules.

Nicotinamide derivatives useful as PDE4 inhibitors

This invention relates to nicotinamide derivatives of general formula (I): in which R1, R2 and R3 have the meanings defined herein, and to processes for the preparation of, intermediates used in the preparation of, compositions containing and the uses of such derivatives.

IMIDAZO(1,2-a)PYRIDINE DERIVATIVE

A compound reprsented by the following formula (I), its salts or nsolvates thereof capable of specifically or selectively expressig an antifungal activity in a broad spectrum based on the novel mechanism thereof of 1,6-β-glucan synthesis inhibition, and an antifungal agent containing any of them.

Cyclo-alkyl substituted benzimidazoles and their use as PARP inhibitors

Compounds of the formula I or II and their tautomeric forms, possible enantiomeric and diastereomeric forms, possible cistrans isomers on the rings in A and prodrugs thereof, pharmaceutical compositions containing these compounds and methods of treating neurodegenerative diseases or neuronal damage with these compounds.

Quinoxaline biphenyl angiotensin II inhibitors

Angiotensin II inhibition is exhibited by STR1 wherein: X is --CH2 -- or O; R is hydrogen, alkyl, aryl, cycloalkyl, aralkyl, or cycloalkylalkyl; R1 and R2 are each independently O or absent; R3 is hydrogen, alkyl, alkenyl, alkoxy, cycloalkyl, aryl, aralkyl, cycloalkylalkyl, halo, haloalkyl, or haloalkoxy; R4 is hydrogen, alkyl, alkenyl, alkoxy, aryl, cycloalkyl, aralkyl, cycloalkylalkyl, --R8 --OH, or --R8 CO2 R9 ; and the remaining symbols are as defined in the specification.